ROCKWELL MEDICAL, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ROCKWELL MEDICAL, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($1.75M) | Nov 12, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($1.49M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($1.49M) | Aug 14, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($1.52M) | May 12, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($1.52M) | Aug 14, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($1.52M) | Nov 12, 2025 |
| Q3 | 2025 | Sep 30, 2024 | $1.66M | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2024 | $343.0K | Aug 14, 2025 |
| Q3 | 2025 | Jun 30, 2024 | $343.0K | Nov 12, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($1.73M) | Aug 14, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($1.73M) | Nov 12, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($1.73M) | May 12, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($1.87M) | Nov 12, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($3.31M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($3.31M) | Aug 8, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($1.75M) | Aug 8, 2024 |
| Q3 | 2024 | Mar 31, 2023 | ($1.75M) | Nov 12, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($1.75M) | May 14, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($4.19M) | Nov 14, 2023 |
| Q3 | 2023 | Jun 30, 2022 | ($4.97M) | Nov 14, 2023 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($1.58M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($1.35M) | Aug 14, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($1.36M) | May 12, 2025 |
| Q3 | 2025 | Sep 30, 2024 | $1.94M | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2024 | $515.0K | Aug 14, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($1.32M) | May 12, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($1.74M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($2.96M) | Aug 8, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($1.43M) | May 14, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($3.71M) | Nov 14, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($4.48M) | Aug 14, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($6.63M) | May 15, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($6.97M) | Nov 14, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($7.82M) | Aug 15, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($7.18M) | May 16, 2022 |
| Q3 | 2021 | Sep 30, 2020 | ($6.69M) | Nov 15, 2021 |
| Q2 | 2021 | Jun 30, 2020 | ($5.60M) | Aug 16, 2021 |
| Q1 | 2021 | Mar 31, 2020 | ($8.06M) | May 17, 2021 |
| Q3 | 2020 | Sep 30, 2019 | ($7.94M) | Nov 9, 2020 |
| Q2 | 2020 | Jun 30, 2019 | ($10.37M) | Aug 10, 2020 |